Results 181 to 190 of about 4,502 (202)

Aprepitant

2013
openaire   +1 more source

Aprepitant/ifosfamide

Reactions Weekly, 2018
openaire   +1 more source

Aprepitant/ifosfamide interaction

Reactions Weekly, 2021
openaire   +1 more source

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

British Journal of Cancer, 2013
N Katakami, Yamaguchi S, Morita S
exaly  

Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

Journal of Clinical Pharmacology, 2012
Ganesh Cherala, , Myrna Y Munar
exaly  

Aprepitant

2010
openaire   +1 more source

Aprepitant and fosaprepitant drug interactions: a systematic review

British Journal of Clinical Pharmacology, 2017
Priya Patel, J Steven Leeder, Micheline Piquette-Miller   +2 more
exaly  

The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug

Investigational New Drugs, 2009
MIGUEL Munoz, Marisa Rosso, Munoz MIGUEL   +2 more
exaly  

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

Supportive Care in Cancer, 2009
Paul J Hesketh, Matti Aapro, Alexandra D Carides   +2 more
exaly  

Aprepitant/erlotinib

Reactions Weekly, 2011
openaire   +1 more source